Barrett & Company’s Steris STE Stock Holding History

Barrett & Company’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-70	Closed	-$12.9K	–	605
2022 Q4	$12.9K	Hold	70	–	–	0.01%	360
2022 Q3	$12.9K	Buy	+70	New	+$14.2K	0.01%	360

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrett & Company's STE Position: Q1 2023 in Review

Barrett & Company sold out of Steris (STE) in Q1 2023, closing a stake of 70 shares — an estimated $12.9K sold.

Barrett & Company first reported a position in STE in Q3 2022 and held it in 2 quarters. The position peaked at $12.9K in Q4 2022. 621 funds tracked by Wall St. Rank hold STE as of Q1 2023.

Barrett & Company reported no remaining Steris position as of Q1 2023 after selling out during the quarter.
Barrett & Company sold 70 Steris shares in Q1 2023, an estimated $12.9K.
Barrett & Company first reported a position in Steris in Q3 2022 and held it in 2 quarters.
Barrett & Company's Steris position peaked at $12.9K in Q4 2022.
621 funds tracked by Wall St. Rank held Steris as of Q1 2023.

Based on Barrett & Company's 13F filing for Q1 2023, filed 11 May 2023.